404
+1-313-307-4176
sales@stratviewresearch.com
Automated Breast Ultrasound Systems Market Report
Automated Breast Ultrasound Systems Market Size, Share, Trends, Forecast & Industry Analysis: 2022-2028
The Automated Breast Ultrasound Systems market is projected to grow from USD 1.57 billion in 2021 to USD 4.45 billion by 2028 at a CAGR of around 15.85% during the forecast period.
Automated breast ultrasound (ABUS) is a breast cancer screening technology used for the detection of dense breast tissue in women. This technology is used as an adjunct to mammography for screening breast cancers in asymptomatic women with dense breasts. Based on the product, it can be categorized as an automated breast ultrasound system (ABUS) and automated breast volume scanner (ABVS).
The growth of the global automated breast ultrasound systems market is primarily driven by the rising number of women suffering from breast cancer. Cancer is the second leading cause of death worldwide and breast cancer is one of the most commonly occurring cancers in women. Growing inclination toward a sedentary lifestyle has also resulted in the rising number of cancer patients. In addition to this, the rising demand for advanced technologies for cancer detection and diagnosis is likely to create lucrative opportunities for the players operating in the global market in the coming years.
The covid-19 outbreak posed significant challenges across verticals worldwide. It impacted the growth of the automated breast ultrasound systems market negatively as the imposition of complete lockdown and restrictions on trade resulted in a decline in visits to hospitals.
Key players operating in the Automated Breast Ultrasound Systems market are-
By application, the automated breast ultrasound systems market has been bifurcated into hospitals and diagnostic centers, clinics, and ambulatory surgical centers. Under these, the hospitals and diagnostic centers segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of required infrastructure and skilled staff in hospitals.
By region, the market in North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to the high adoption rate of advanced technologies in the healthcare industry coupled with the presence of key market players such as GE Healthcare (US) and SonoCiné Inc. (US). The market growth in the Asia-Pacific region is expected to be driven by the rising number of people suffering from cancer.
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
Here is the list of the group of customers that the automated breast ultrasound systems market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
The automated breast ultrasound systems market is expected to witness an impressive growth of 15.85% CAGR during 2022-2028.
GE Healthcare (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), SonoCiné Inc. (US), Qview Medical (US), Seno Medical Instruments (US), Volpara Solutions Limited (New Zealand), Delphinus Medical Technologies, Inc. (US), CapeRay (South Af-rica), SuperSonic Imagine, Inc. (France), Nova Medical Inc (US), Theraclion (France), Metritrack Inc (US) and Toshiba Corporation (Japan) are among the key players in the market.
The automated breast ultrasound systems market size is expected to reach USD 4.45 billion in 2028.
The hospitals and diagnostic centers segment is expected to register significant growth in the market in the coming years.
North America accounted for the largest share in the market in 2021.
Automated breast ultrasound systems distributors, Automated breast ultrasound systems suppliers, Automated breast ultrasound systems manufacturers, Logistics organizations, Government bodies are the target audience in the market.
WE ACCEPT
